Keyphrases
People Living with HIV (PLHIV)
100%
Open-label Extension
100%
African Women
100%
HIV-1 Prevention
100%
Dapivirine Vaginal Ring
100%
Dapivirine
62%
Human Immunodeficiency Virus Type 1 (HIV-1)
37%
HIV Incidence
37%
Human Development
12%
Children's Health
12%
Health Development
12%
Uganda
12%
Sexually Transmitted Infections
12%
Placebo
12%
Adverse Events
12%
South Africa
12%
Placebo Groups
12%
Phase III Clinical Trial
12%
Phase II Trial
12%
Malawi
12%
Infectious Diseases
12%
Serious Adverse Events
12%
Surrogate Marker
12%
Trial Network
12%
Serological Test
12%
Zimbabwe
12%
National Institute of Mental Health
12%
HIV-1 Infection
12%
Study Support
12%
Clinical Research Center
12%
U.S. National Institutes of Health
12%
Kennedy
12%
Allergy Disease
12%
High Background
12%
Microbicide Trials
12%
Background Rates
12%
Women in Africa
12%
Label Set
12%
Vaginal Ring
12%
Persistent Use
12%
Extension Trial
12%
Residual Amount
12%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Vagina Ring
100%
Dapivirine
100%
Infection
15%
Adverse Event
15%
Placebo
15%
Clinical Research
7%
Child Health
7%
Human Development
7%
Mental Health
7%
Clinical Trial
7%
Disease Marker
7%
Microbicide
7%
Human Immunodeficiency Virus 1 Infection
7%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Dapivirine
100%
Placebo
15%
Adverse Event
15%
Infection
15%
Clinical Trial
7%
Human Immunodeficiency Virus 1 Infection
7%
Clinical Research
7%
Microbicide
7%
Disease Marker
7%